Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]
Low-Dose Naltrexone Evaluated for Neuropathic Corneal Pain (Abstract)
Low-Dose Naltrexone Evaluated for Neuropathic Corneal Pain
MPR First Report
14 October 2019
Among patients with neuropathic corneal pain, adjunctive treatment with low-dose naltrexone was found to be effective and well-tolerated, according to data presented at the 2019 American Academy of Ophthalmology Meeting in San Francisco, CA.
Keywords: low-dose naltrexone, neuropathic, corneal pain
Keywords by Erin Williams, student, St. Louis College of Pharmacy